EXPE vs RANI · P/E 20, rev $7.74B vs rev $3.4M
Expedia Group Inc. (EXPE) versus Rani Therapeutics Holdings Inc (RANI) — a side-by-side from cached financials, not a winner call.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Rani Therapeutics Holdings Inc (RANI) is a biotechnology company listed on US.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Latest reported RANI revenue for 2026-06-30 was $3.4M. Net income was -$14.4M. Revenue was up 100.0% from 2026-03-31 to 2026-06-30. RANI currently screens at market cap $41.5M.
EXPE currently screens at market cap $21.71B and trailing P/E 20.4. RANI currently screens at market cap $41.5M.
Not investment advice. Open the EXPE and RANI stock pages for the full models.
Not investment advice.